Case Study: Global Pharmaceutical Company strengthens third-party risk management with Genpact

Sustaining a pharma company’s good name with third-party risk management

Global Pharmaceutical Company worked with Genpact to address growing third-party risk management challenges across its global supplier base. With regulators paying closer attention to third-party risk, the company needed a better way to assess thousands of vendors, ensure compliance with legal and corporate standards, and produce timely, accurate risk reports.

Genpact implemented a scalable, standardized TPRM process supported by technology, including risk assessment, due diligence, monitoring, reporting, and governance. As a result, Global Pharmaceutical Company can now assess nearly 100% of its strategic third parties above a certain spend threshold, has cut assessment cycle time by up to 40%, eliminated duplicate assessments, improved reporting accuracy, and strengthened its sustainability ranking and supplier relationships.